Scientific Brainstorming
Purpose and boundaries
Use this skill to create, organize, challenge, and transparently prioritize
candidate research directions. Treat every output as a proposal, not a
finding. Creativity methods can alter participation and idea yield, but no
method universally improves originality, usefulness, or scientific validity.
The evidence base and its limits are summarized in
references/sources.md.
Keep these activities separate:
- Ideation creates questions, mechanisms, alternatives, or study concepts.
- Evidence assessment checks what reliable literature and data support.
- Hypothesis validation requires observations, predictions, suitable
designs, analyses, and independent scrutiny; brainstorming cannot validate a
hypothesis.
- Ethics, biosafety, dual-use, regulatory, and institutional review require
the relevant authorized reviewers. A brainstorm is never approval.
- Clinical advice requires qualified clinicians and patient-specific
context. Do not turn research ideas into diagnosis or treatment guidance.
For an observation-led testable hypothesis, hand off to
hypothesis-generation. For study architecture, use experimental-design;
for sample size, statistical-power; for existing evidence,
literature-review; and for analysis, statistical-analysis.
Operating rules
- Label claims as idea, assumption, prediction, located
evidence, or decision. Never blur these categories.
- Generate independently before exposing participants to other people's or
AI-generated ideas. Face-to-face turn-taking can block production, and
examples can anchor later output.
- Preserve minority views, negative evidence, uncertainty, and abstentions.
Consensus is not truth and vote counts are not effect sizes.
- Record provenance without exposing confidential, personal, controlled, or
unpublished information.
- Define evaluation criteria and directions before scoring. Keep raw ratings,
reasons, ranges, and disagreement visible.
- Search the literature after an initial independent round when practical,
then deliberately reopen ideation. This reduces early anchoring without
mistaking an incomplete search for a research gap.
- Do not automatically select a “winner.” Scores are traceable decision aids;
qualitative judgment, uncertainty, feasibility, and ethics gates remain
controlling.
Reproducible workflow
1. Scope the session
Write one focal question and record:
- purpose, audience, decision owner, and time horizon;
- in-scope and out-of-scope topics;
- constraints that are real, assumed, negotiable, or unknown;
- current knowledge, unresolved observations, and prohibited outputs;
- whether human participants, animals, clinical care, sensitive data,
pathogens, controlled technologies, or environmental release could be
implicated.
If the request seeks patient-specific care, evasion of oversight, harmful
optimization, or operationally enabling dual-use details, stop ideation and
route to the appropriate professional or institutional process.
2. Diversify perspectives deliberately
Invite relevant methodological, domain, implementation, statistical, safety,
ethics, stakeholder, and lived-experience perspectives. Diversity is not a
guarantee of creativity: explain whose perspective is represented, missing, or
structurally disadvantaged. Use accessible participation modes and
pseudonymous participant IDs where appropriate.
The facilitator should disclose conflicts, avoid offering a preferred answer
first, prevent senior members from dominating, and ask leaders to contribute
after the independent round.
3. Generate independently
Give everyone the same neutral prompt, constraints, and fixed time window.
Participants write ideas privately and in parallel before discussion. For each
idea, capture:
- a stable ID and one-sentence statement;
- contributor ID(s) and stage (
independent, discussion, or post-check);
- origin (
human, AI-assisted, literature-inspired, mixed, or other);
- assumptions, predicted observations, uncertainties, and possible
disconfirming evidence;
- source identifiers for literature-inspired ideas and tool/purpose disclosure
for AI assistance.
Do not show example solutions before this round unless examples are necessary;
if they are, record them as potential anchors.
4. Share without immediate evaluation
Use round-robin or pooled silent sharing. Clarify wording without advocacy.
Permit a private or anonymous channel. Ask each participant what is missing,
what contradicts the dominant framing, and which idea became less obvious
after hearing the group.
5. Cluster structurally
Group ideas by an explicit relation such as shared outcome, mechanism,
population, scale, or method. Keep original IDs and text. Record merges and
splits. Similar wording is not proof of semantic equivalence; retain distinct
ideas when their assumptions, intervention, population, or predictions differ.
See references/facilitation_workflows.md.
6. Define transparent criteria
Before rating, define each criterion, direction, scale anchors, evidence
needed, conflicts, and explicit weights. Common dimensions include:
- potential information gain and discriminating predictions;
- relevance to the scoped question;
- originality relative to the checked literature, not merely to the room;
- feasibility, resources, and reversibility;
- methodological rigor and vulnerability to bias;
- ethics, safety, equity, dual-use, and regulatory burden;
- value if the result is null or contradicts the favored mechanism.
Use ranges or confidence labels where assessors are uncertain. Do not hide
vetoes inside an averaged score. See references/idea_evaluation.md.
7. Run adversarial review
Assign a reviewer who did not originate each shortlisted idea. Ask:
- What observation would make this idea wrong or uninformative?
- Which alternative explanation fits the same predicted result?
- What hidden dependency, measurement failure, confounder, or selection effect
could dominate?
- Are authority, anchoring, group loyalty, publication incentives, or an
attractive technology driving preference?
- Could this cause harm, worsen inequity, expose sensitive information, or
enable misuse?
Record the response, mitigation, residual uncertainty, and whether the idea was
revised—not just pass/fail.
8. Check literature and evidence
Search authoritative databases, primary studies, methods guidance, negative
results, and adjacent fields. Verify every citation at its source. For each
idea, record query/date, sources screened, evidence for and against, and search
limits. Use statuses such as not-checked, search-incomplete,
support-located, challenge-located, or mixed.
Absence from a bounded search does not establish novelty, and supportive
literature does not validate a new mechanism. Reopen one short independent
generation round after the evidence check.
9. Apply feasibility, rigor, and ethics gates
Before advancing an idea, identify the appropriate domain review:
- For biomedical work, consider rigor of prior research, robust design,
relevant biological variables, and resource authentication. When NIH policy
applies, sex as a biological variable should be considered from the research
question through design, analysis, and reporting; justify a single-sex scope
with relevant evidence.
- Route human-subjects, animal, biosafety, data-governance, export-control,
clinical, environmental, and other regulated work to the relevant office.
- Screen life-science and enabling-technology ideas for dual-use or misuse
potential early. Current U.S. oversight is evolving; consult the institution
and current agency policy rather than relying on a static checklist.
- Do not upload sensitive, unpublished, proprietary, controlled, or personal
information to an external AI service.
An ethics or feasibility concern may require redesign, controlled handling, or
stopping. A high creativity score never overrides a gate.
10. Decide and log
The accountable human decision owner records:
- candidates considered and criteria/weights used;
- raw ratings, uncertainty ranges, dissent, abstentions, and sensitivity
results;
- literature and review dates;
- gate outcomes and required approvals;
- decision, rationale, rejected alternatives, unresolved risks, owner, and
revisit trigger.
Label the next action correctly: further search, consultation, simulation,
pilot design, protocol development, preregistration, or no action. If a
confirmatory study is planned, preregister hypotheses and analysis decisions
before outcomes are known; report later deviations and exploratory work
transparently. Preregistration improves transparency but is not peer review,
ethical approval, or proof of validity.
Bias and failure controls
- Production blocking: private parallel generation before oral discussion.
- Anchoring and design fixation: no leader answer or AI examples until the
independent round; reopen generation after evidence review.
- Authority and status effects: leader-last sharing, anonymous input,
independent ratings, and visible dissent.
- Groupthink: assign a genuine alternative-generation role, invite outside
review, and document rejected options. Treat “groupthink” as a family of
risks, not a single universally established diagnosis.
- Evaluation apprehension: separate contribution from attribution where
possible; critique ideas, not contributors.
- Premature convergence: fixed divergence window followed by an explicit
transition and predeclared criteria.
- False precision: use anchored scales, uncertainty ranges, sensitivity
analysis, and narrative review.
- Research-gap inflation: record search boundaries and use “no direct
evidence located,” not “never studied.”
- AI hallucination or homogenization: human-first ideation, provenance,
independent verification, multiple non-AI perspectives, and comparison for
suspiciously repeated frames. See
references/responsible_ai.md.
Optional local CLIs
The scripts are deterministic, standard-library utilities. They do not call a
network service, LLM, or scientific database and do not make scientific
conclusions.
python scripts/session_scaffold.py --help
python scripts/validate_register.py --help
python scripts/evaluate_matrix.py --help
Create a session register:
python scripts/session_scaffold.py \
--session-id "microbiome-01" \
--title "Microbiome mechanism ideation" \
--question "Which mechanisms could explain the scoped observation?" \
--participant P01 --participant P02 \
--output session.json
Validate structure and provenance:
python scripts/validate_register.py session.json --output validation.json
Calculate a fully disclosed weighted matrix from CSV, including score intervals
and one-at-a-time weight sensitivity:
python scripts/evaluate_matrix.py scores.csv \
--config criteria.json \
--weight-delta 0.10 \
--output matrix.json
Outputs refuse symlinks and existing files unless --force is explicit; inputs
and collection sizes are bounded. The validator checks structure, not truth.
The matrix preserves qualitative review and uncertainty and leaves
decision null. Input formats and interpretation are documented in
references/idea_evaluation.md.
Reference index
references/brainstorming_methods.md — evidence-calibrated method selection,
nominal groups, Delphi, structured elicitation, and creative prompts.
references/facilitation_workflows.md — ready-to-run individual, group, and
asynchronous session protocols plus provenance templates.
references/idea_evaluation.md — criteria, scoring formula, uncertainty,
sensitivity analysis, gates, and decision logs.
references/responsible_ai.md — accountable AI assistance, confidentiality,
hallucination, homogenization, disclosure, dual-use, and integrity.
references/sources.md — dated primary studies and official guidance
consulted for this version.
1---2name: scientific-brainstorming3description: Facilitates evidence-aware scientific ideation with independent generation, structured discussion, explicit assumptions, transparent evaluation, adversarial review, and decision logs. Use for early-stage research brainstorming or prioritizing candidate directions; hand off empirical validation, study design, ethics or regulatory review, and clinical questions to appropriate experts or skills.4license: MIT5---6
7# Scientific Brainstorming
8
9## Purpose and boundaries
10
11Use this skill to create, organize, challenge, and transparently prioritize
12candidate research directions. Treat every output as a **proposal**, not a
13finding. Creativity methods can alter participation and idea yield, but no
14method universally improves originality, usefulness, or scientific validity.
15The evidence base and its limits are summarized in
16`references/sources.md`.
17
18Keep these activities separate:
19
20- **Ideation** creates questions, mechanisms, alternatives, or study concepts.
21- **Evidence assessment** checks what reliable literature and data support.
22- **Hypothesis validation** requires observations, predictions, suitable
23 designs, analyses, and independent scrutiny; brainstorming cannot validate a
24 hypothesis.
25- **Ethics, biosafety, dual-use, regulatory, and institutional review** require
26 the relevant authorized reviewers. A brainstorm is never approval.
27- **Clinical advice** requires qualified clinicians and patient-specific
28 context. Do not turn research ideas into diagnosis or treatment guidance.
29
30For an observation-led testable hypothesis, hand off to
31`hypothesis-generation`. For study architecture, use `experimental-design`;
32for sample size, `statistical-power`; for existing evidence,
33`literature-review`; and for analysis, `statistical-analysis`.
34
35## Operating rules
36
371. Label claims as **idea**, **assumption**, **prediction**, **located
38 evidence**, or **decision**. Never blur these categories.
392. Generate independently before exposing participants to other people's or
40 AI-generated ideas. Face-to-face turn-taking can block production, and
41 examples can anchor later output.
423. Preserve minority views, negative evidence, uncertainty, and abstentions.
43 Consensus is not truth and vote counts are not effect sizes.
444. Record provenance without exposing confidential, personal, controlled, or
45 unpublished information.
465. Define evaluation criteria and directions before scoring. Keep raw ratings,
47 reasons, ranges, and disagreement visible.
486. Search the literature **after an initial independent round** when practical,
49 then deliberately reopen ideation. This reduces early anchoring without
50 mistaking an incomplete search for a research gap.
517. Do not automatically select a “winner.” Scores are traceable decision aids;
52 qualitative judgment, uncertainty, feasibility, and ethics gates remain
53 controlling.
54
55## Reproducible workflow
56
57### 1. Scope the session
58
59Write one focal question and record:
60
61- purpose, audience, decision owner, and time horizon;
62- in-scope and out-of-scope topics;
63- constraints that are real, assumed, negotiable, or unknown;
64- current knowledge, unresolved observations, and prohibited outputs;
65- whether human participants, animals, clinical care, sensitive data,
66 pathogens, controlled technologies, or environmental release could be
67 implicated.
68
69If the request seeks patient-specific care, evasion of oversight, harmful
70optimization, or operationally enabling dual-use details, stop ideation and
71route to the appropriate professional or institutional process.
72
73### 2. Diversify perspectives deliberately
74
75Invite relevant methodological, domain, implementation, statistical, safety,
76ethics, stakeholder, and lived-experience perspectives. Diversity is not a
77guarantee of creativity: explain whose perspective is represented, missing, or
78structurally disadvantaged. Use accessible participation modes and
79pseudonymous participant IDs where appropriate.
80
81The facilitator should disclose conflicts, avoid offering a preferred answer
82first, prevent senior members from dominating, and ask leaders to contribute
83after the independent round.
84
85### 3. Generate independently
86
87Give everyone the same neutral prompt, constraints, and fixed time window.
88Participants write ideas privately and in parallel before discussion. For each
89idea, capture:
90
91- a stable ID and one-sentence statement;
92- contributor ID(s) and stage (`independent`, `discussion`, or `post-check`);
93- origin (`human`, `AI-assisted`, `literature-inspired`, `mixed`, or `other`);
94- assumptions, predicted observations, uncertainties, and possible
95 disconfirming evidence;
96- source identifiers for literature-inspired ideas and tool/purpose disclosure
97 for AI assistance.
98
99Do not show example solutions before this round unless examples are necessary;
100if they are, record them as potential anchors.
101
102### 4. Share without immediate evaluation
103
104Use round-robin or pooled silent sharing. Clarify wording without advocacy.
105Permit a private or anonymous channel. Ask each participant what is missing,
106what contradicts the dominant framing, and which idea became less obvious
107after hearing the group.
108
109### 5. Cluster structurally
110
111Group ideas by an explicit relation such as shared outcome, mechanism,
112population, scale, or method. Keep original IDs and text. Record merges and
113splits. Similar wording is not proof of semantic equivalence; retain distinct
114ideas when their assumptions, intervention, population, or predictions differ.
115See `references/facilitation_workflows.md`.
116
117### 6. Define transparent criteria
118
119Before rating, define each criterion, direction, scale anchors, evidence
120needed, conflicts, and explicit weights. Common dimensions include:
121
122- potential information gain and discriminating predictions;
123- relevance to the scoped question;
124- originality relative to the checked literature, not merely to the room;
125- feasibility, resources, and reversibility;
126- methodological rigor and vulnerability to bias;
127- ethics, safety, equity, dual-use, and regulatory burden;
128- value if the result is null or contradicts the favored mechanism.
129
130Use ranges or confidence labels where assessors are uncertain. Do not hide
131vetoes inside an averaged score. See `references/idea_evaluation.md`.
132
133### 7. Run adversarial review
134
135Assign a reviewer who did not originate each shortlisted idea. Ask:
136
137- What observation would make this idea wrong or uninformative?
138- Which alternative explanation fits the same predicted result?
139- What hidden dependency, measurement failure, confounder, or selection effect
140 could dominate?
141- Are authority, anchoring, group loyalty, publication incentives, or an
142 attractive technology driving preference?
143- Could this cause harm, worsen inequity, expose sensitive information, or
144 enable misuse?
145
146Record the response, mitigation, residual uncertainty, and whether the idea was
147revised—not just pass/fail.
148
149### 8. Check literature and evidence
150
151Search authoritative databases, primary studies, methods guidance, negative
152results, and adjacent fields. Verify every citation at its source. For each
153idea, record query/date, sources screened, evidence for and against, and search
154limits. Use statuses such as `not-checked`, `search-incomplete`,
155`support-located`, `challenge-located`, or `mixed`.
156
157Absence from a bounded search does not establish novelty, and supportive
158literature does not validate a new mechanism. Reopen one short independent
159generation round after the evidence check.
160
161### 9. Apply feasibility, rigor, and ethics gates
162
163Before advancing an idea, identify the appropriate domain review:
164
165- For biomedical work, consider rigor of prior research, robust design,
166 relevant biological variables, and resource authentication. When NIH policy
167 applies, sex as a biological variable should be considered from the research
168 question through design, analysis, and reporting; justify a single-sex scope
169 with relevant evidence.
170- Route human-subjects, animal, biosafety, data-governance, export-control,
171 clinical, environmental, and other regulated work to the relevant office.
172- Screen life-science and enabling-technology ideas for dual-use or misuse
173 potential early. Current U.S. oversight is evolving; consult the institution
174 and current agency policy rather than relying on a static checklist.
175- Do not upload sensitive, unpublished, proprietary, controlled, or personal
176 information to an external AI service.
177
178An ethics or feasibility concern may require redesign, controlled handling, or
179stopping. A high creativity score never overrides a gate.
180
181### 10. Decide and log
182
183The accountable human decision owner records:
184
185- candidates considered and criteria/weights used;
186- raw ratings, uncertainty ranges, dissent, abstentions, and sensitivity
187 results;
188- literature and review dates;
189- gate outcomes and required approvals;
190- decision, rationale, rejected alternatives, unresolved risks, owner, and
191 revisit trigger.
192
193Label the next action correctly: further search, consultation, simulation,
194pilot design, protocol development, preregistration, or no action. If a
195confirmatory study is planned, preregister hypotheses and analysis decisions
196before outcomes are known; report later deviations and exploratory work
197transparently. Preregistration improves transparency but is not peer review,
198ethical approval, or proof of validity.
199
200## Bias and failure controls
201
202- **Production blocking:** private parallel generation before oral discussion.
203- **Anchoring and design fixation:** no leader answer or AI examples until the
204 independent round; reopen generation after evidence review.
205- **Authority and status effects:** leader-last sharing, anonymous input,
206 independent ratings, and visible dissent.
207- **Groupthink:** assign a genuine alternative-generation role, invite outside
208 review, and document rejected options. Treat “groupthink” as a family of
209 risks, not a single universally established diagnosis.
210- **Evaluation apprehension:** separate contribution from attribution where
211 possible; critique ideas, not contributors.
212- **Premature convergence:** fixed divergence window followed by an explicit
213 transition and predeclared criteria.
214- **False precision:** use anchored scales, uncertainty ranges, sensitivity
215 analysis, and narrative review.
216- **Research-gap inflation:** record search boundaries and use “no direct
217 evidence located,” not “never studied.”
218- **AI hallucination or homogenization:** human-first ideation, provenance,
219 independent verification, multiple non-AI perspectives, and comparison for
220 suspiciously repeated frames. See `references/responsible_ai.md`.
221
222## Optional local CLIs
223
224The scripts are deterministic, standard-library utilities. They do not call a
225network service, LLM, or scientific database and do not make scientific
226conclusions.
227
228```bash
229python scripts/session_scaffold.py --help
230python scripts/validate_register.py --help
231python scripts/evaluate_matrix.py --help
232```
233
234Create a session register:
235
236```bash
237python scripts/session_scaffold.py \
238 --session-id "microbiome-01" \
239 --title "Microbiome mechanism ideation" \
240 --question "Which mechanisms could explain the scoped observation?" \
241 --participant P01 --participant P02 \
242 --output session.json
243```
244
245Validate structure and provenance:
246
247```bash
248python scripts/validate_register.py session.json --output validation.json
249```
250
251Calculate a fully disclosed weighted matrix from CSV, including score intervals
252and one-at-a-time weight sensitivity:
253
254```bash
255python scripts/evaluate_matrix.py scores.csv \
256 --config criteria.json \
257 --weight-delta 0.10 \
258 --output matrix.json
259```
260
261Outputs refuse symlinks and existing files unless `--force` is explicit; inputs
262and collection sizes are bounded. The validator checks structure, not truth.
263The matrix preserves qualitative review and uncertainty and leaves
264`decision` null. Input formats and interpretation are documented in
265`references/idea_evaluation.md`.
266
267## Reference index
268
269- `references/brainstorming_methods.md` — evidence-calibrated method selection,
270 nominal groups, Delphi, structured elicitation, and creative prompts.
271- `references/facilitation_workflows.md` — ready-to-run individual, group, and
272 asynchronous session protocols plus provenance templates.
273- `references/idea_evaluation.md` — criteria, scoring formula, uncertainty,
274 sensitivity analysis, gates, and decision logs.
275- `references/responsible_ai.md` — accountable AI assistance, confidentiality,
276 hallucination, homogenization, disclosure, dual-use, and integrity.
277- `references/sources.md` — dated primary studies and official guidance
278 consulted for this version.